Is Henry Schein Inc (HSIC) overvalued? · P/E 24, rev $6.83B
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
This page asks whether Henry Schein Inc (HSIC) looks expensive on cached numbers — not a short thesis.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next HSIC 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the HSIC stock page for the full model, not this heading.
Not investment advice.